http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04173795-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_046e16bd6918ef3cd62184605b15a413
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
filingDate 1990-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ff753f73ca3f3b68439f69c88d89baf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf89e2bf52677b18b9f03e8139a4f199
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d2988eefe998cf162a3e4deba589edb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5fb63434c60db5d598d3009a0e409f7
publicationDate 1992-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H04173795-A
titleOfInvention Production of (1'r,3s)-3-(1'-trisubstituted-silyloxyethyl)-azetidin-2-one
abstract PURPOSE: To obtain the subject compound useful as an intermediate for carbapenem antibiotic substance by reacting aminomethylhydroxybutyric acid with trisubstituted silyl chloride, adding dibenzothiazolyl disulfide, etc., and triphenylphosphine to the system and reacting the components. n CONSTITUTION: The objective compound of formula II can be produced by reacting (2S,3R)-2-aminomethyl-3-hydroxybutyric acid of formula I with a trisubstituted silyl chloride (e.g. tert butyldimethylsilyl chloride) in the presence of a base, adding 2,2'-dibenzothiazolyl disulfide or 2,2'-dibenzimidazolyl disulfide and triphenylphosphine to the system and reacting the components. n COPYRIGHT: (C)1992,JPO&Japio
priorityDate 1990-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13293131
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428573155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76223824
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406970473
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407380276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415716027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421418087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412208
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10975521

Total number of triples: 31.